CHRONOTHERAPEUTIC DILTIAZEM FORMULATIONS AND THE ADMINISTRATION THEREOF
Details for Australian Patent Application No. 2003270349 (hide)
International Classifications
Event Publications
15 January 2004 Complete Application Filed
Priority application(s): 60/408,872 09.09.02 US
13 May 2004 Application Open to Public Inspection
Published as AU-A-2003270349
13 April 2006 Change of Name(s) of Applicant(s), Section 104
Biovail Laboratorties Inc. The name of the applicant has been changed to Biovail Laboratories Inc. 2004
2 August 2007 Assignment before Grant
Biovail Laboratories Inc. The application has been assigned to Biovail Laboratories International S.R.L.
2 April 2009 Application Lapsed, Refused Or Withdrawn, Patent Ceased or Expired
This application lapsed under section 142(2)(d). Examination has been requested or an examination report has issued for this application. Note that applications or patents shown as lapsed or ceased may be restored at a later date.
Legal
The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.
Next and Previous Patents/Applications
2003270350-ISOXAZOLES AND THEIR USE IN THE TREATMENT OF ISCHEMIC DISEASES
2003270348-Compositions and methods for the diagnosis and treatment of tumor
IP Reporting Samples
Customised IP Reporting
IP Insider for IP Professionals
IP Monitor Professional
- Editable Word format reports
- For IP Professionals
- Multiuser